Activation of p38 mitogen-activated protein kinase in ovalbumin and ozone-induced mouse model of asthma

Respirology

Volumn 18, Issue , 2013, Pages 20-29

  Liang, Li ^a   Li, Feng ^a   Bao, Aihua ^a   Zhang, Min ^a   Chung, Kian Fan ^b   Zhou, Xin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; Glucocorticoid; Ozone; P38 mitogenactivated protein kinase

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; COLLAGEN; DEXAMETHASONE; HEAT SHOCK PROTEIN 27; INTERLEUKIN 13; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OVALBUMIN; OZONE; TUMOR NECROSIS FACTOR; CORTICOSTEROID; DUSP1 PROTEIN, MOUSE; ENZYME INHIBITOR; GLUCOCORTICOID; HSPB2 PROTEIN, MOUSE; IMIDAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHIAL WALL THICKNESS; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HISTOLOGY; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; LUNG; METABOLISM; P38 MITOGEN-ACTIVATED PROTEIN KINASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ASTHMA; GLUCOCORTICOID; OZONE; P38 MITOGEN-ACTIVATED PROTEIN KINASE;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME INHIBITORS; HSP27 HEAT-SHOCK PROTEINS; IMIDAZOLES; LUNG; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; OZONE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIMIDINES; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84896315031     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12189     Document Type: Article

References (34)

1. Global Initiative for Asthma (GINA). The global burden of asthma report. 2011 update.
2. Pan G, Zhang S, Feng Y et al. Air pollution and children’s respiratory symptoms in six cities of Northern China. Respir. Med. 2010; 104: 1903-11.
3. Kelly FJ, Fussell JC. Air pollution and airway disease. Clin. Exp. Allergy 2011; 41: 1059-71.
4. Cho HY, Zhang LY, Kleeberger SR et al. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001; 280: L537-46.
5. Moore PE, Church TL, Chism DD et al. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell.Mol. Physiol. 2002; 282: L847-53.
6. Depuydt PO, Lambrecht BN, Joos GF et al. Effect of ozone exposure on allergic sensitization and airway inflammation induced by dendritic cells. Clin. Exp. Allergy 2002; 32: 391-6.
7. Jang AS, Choi IS, Takizawa H et al. Additive effect of diesel exhaust particulates and ozone on airway hyperresponsiveness and inflammation in a mouse model of asthma. J. Korean Med. Sci. 2005; 20: 759-63.
8. Jang AS, Choi IS, Lee JH et al. Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling. Respir. Res. 2006; 7: 24.
9. Nath P, Leung SY, Williams A et al. Importance of p38 mitogenactivated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur. J. Pharmacol. 2006; 544: 160-7.
10. Williams AS, Issa R, Durham A et al. Role of p38 mitogenactivated protein kinase in ozone-induced airway hyperresponsiveness and inflammation. Eur. J. Pharmacol. 2008; 600: 117-22.
11. Chung KF. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest 2011; 139: 1470-9.
12. Abraham SM, Lawrence T, Kleiman A et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J. Exp.Med. 2006; 203: 1883-9.
13. Abraham SM, Clark AR. Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem. Soc. Trans. 2006; 34: 1018-23.
14. Lasa M, Abraham SM, Boucheron C et al. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 2002; 22: 7802-11.
15. Li F, Zhang M, Hussain F et al. Inhibition of p38 MAPKdependent bronchial contraction after ozone by corticosteroids. Eur. Respir. J. 2011; 37: 933-42.
16. Bhavsar P, Khorasani N, Hew M et al. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur. Respir. J. 2010; 35: 750-6.
17. Chang PJ, Bhavsar PK, Michaeloudes C et al. Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma. J. Allergy Clin. Immunol. 2012; 130: 877-85.
18. Kwak YG, Song CH, Yi HK et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 2003; 111: 1083-92.
19. Braber S, Henricks PA, Nijkamp FP et al. Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation. Respir.Res. 2010; 11: 99.
20. McMillan SJ, Xanthou G, Lloyd CM et al. Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin. Exp. Allergy 2005; 35: 388-96.
21. Leigh R, Ellis R, Wattie J et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 2002; 27: 526-35.
22. Bhavsar PK, Levy BD, Hew MJ et al. Corticosteroid suppression of lipoxin A4 and leukotriene B4 from alveolar macrophages in severe asthma. Respir. Res. 2010; 11: 71.
23. Mercado N, Hakim A, Kobayashi Y et al. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PLoS ONE 2012; 7: e41582.
24. Boldogh I, Bacsi A, Choudhury BK et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigeninduced allergic airway inflammation. J. Clin. Invest. 2005; 115: 2169-79.
25. Chan RC, Wang M, Li N et al. Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J. Allergy Clin. Immunol. 2006; 118: 455-65.
26. Brightling C, Berry M, Amrani Y et al. Targeting TNF-alpha: a novel therapeutic approach for asthma. J.Allergy Clin. Immunol. 2008; 121: 5-10; quiz 1-2.
27. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004; 202: 175-90.
28. Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J. Allergy Clin. Immunol. 2007; 119: 1055-62; quiz 63-4.
29. Hansbro PM, Kaiko GE, Foster PS et al. Cytokine/anti-cytokine therapy—novel treatments for asthma? Br. J. Pharmacol. 2011; 163: 81-95.
30. Alfaro-Moreno E, Martinez L, Garcia-Cuellar C et al. Biologic effects induced in vitro by PM10 from three different zones of Mexico City. Environ. Health Perspect. 2002; 110: 715-20.
31. Alford KA, Glennie S, Turrell BR et al. Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling. J. Biol. Chem. 2007; 282: 6232-41.
32. Mayer RJ, Callahan JF. P38 MAP kinase inhibitors: a future therapy for inflammatory diseases. Drug Discov. Today Ther. Strateg. 2006; 3: 49-54.
33. Manetsch M, Che W, Seidel P et al. MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells. Cell. Signal. 2012; 24: 907-13.
34. Mercado N, To Y, Kobayashi Y et al. p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma. Mol. Pharmacol. 2011; 80: 1128-35.